Line 1: |
Line 1: |
− | [[|centre|500px]]
| + | {{Manson |
| + | |book = Small Animal Abdominal and Metabolic Disorders Q&A}} |
| | | |
| + | [[File:SmAn Ab and Met 04a.jpg|centre|500px]] |
| + | <br> |
| + | [[File:SmAn Ab and Met 04b.jpg|centre|500px]] |
| + | <br> |
| + | [[File:SmAn Ab and Met 04c.png|centre|500px]] |
| <br /> | | <br /> |
| | | |
Line 11: |
Line 17: |
| |a1= | | |a1= |
| The erosive crusting of the nasal planum, oral mucocutaneous junctions, foot pads and genitalia can occur in diseases such as pemphigus foliaceus, drug eruption, lupus erythematosus, necrolytic migratory erythema, zinc-responsive dermatosis and generic dog food dermatoses. | | The erosive crusting of the nasal planum, oral mucocutaneous junctions, foot pads and genitalia can occur in diseases such as pemphigus foliaceus, drug eruption, lupus erythematosus, necrolytic migratory erythema, zinc-responsive dermatosis and generic dog food dermatoses. |
− | |l1= | + | |l1=Hepatocutaneous Syndrome |
| |q2=Could there be a connection between the skin lesions and the biochemical and ultrasonographic abnormalities? | | |q2=Could there be a connection between the skin lesions and the biochemical and ultrasonographic abnormalities? |
| |a2= | | |a2= |
Line 17: |
Line 23: |
| | | |
| The ultrasound of the liver demonstrates the patchy appearance of hypoechoic nodules within a hyperechoic background which is characteristic of this disease. | | The ultrasound of the liver demonstrates the patchy appearance of hypoechoic nodules within a hyperechoic background which is characteristic of this disease. |
− | |l2= | + | |l2=Hepatocutaneous Syndrome |
| |q3=What further diagnostic tests are indicated? | | |q3=What further diagnostic tests are indicated? |
| |a3= | | |a3= |
Line 25: |
Line 31: |
| | | |
| In humans this syndrome is most often associated with a glucagon-secreting pancreatic tumour. In dogs, glucagonomas have been identified but are very rare. | | In humans this syndrome is most often associated with a glucagon-secreting pancreatic tumour. In dogs, glucagonomas have been identified but are very rare. |
− | |l3= | + | |l3=Hepatocutaneous Syndrome#Diagnosis |
| |q4=What are the treatment options and prognosis? | | |q4=What are the treatment options and prognosis? |
| |a4= | | |a4= |
Line 33: |
Line 39: |
| | | |
| Unfortunately, the prognosis of affected dogs is poor to guarded. | | Unfortunately, the prognosis of affected dogs is poor to guarded. |
− | |l4= | + | |l4=Hepatocutaneous Syndrome#Treatment |
| </FlashCard> | | </FlashCard> |
| | | |